Another report also suggests that TGFβ primes human breast cancer cells to lung metastasis through the activation of Angiopoietin-like 4 (ANGPTL4) which disrupts endothelial cell-cell junctions, thus permitting metastatic breast cells to extravasate and initiate metastatic colonies in the lung [145]. Here, ANGPTL4 is linked to breast carcinoma.